Ipsen shares are closing back in on major support levels around 106.8 EUR based on daily price data, which could offer attractive entry points. | June 1, 2023
REGULATED INFORMATION COMBINED SHAREHOLDERS’ MEETING OF IPSEN S.A.HELD ON 31 MAY 2023 ALL THE RESOLUTIONS SUBMITTED TO THE SHAREHOLDERS’ VOTE HAVE BEEN APPROVED Paris , 31 May. | May 31, 2023
Ipsen shares are trading close to a resistance zone which currently limits any upside potential. We expect that this level will be broken due to the stock s technical chart pattern. | May 4, 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / May 3, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 3, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance Paris , 27 April 2023Ipsen , a global specialty-driven biopharmaceutical company,. | April 27, 2023